What's breaking now, across thousands of outlets.
The government has announced “most-favored-nation” pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the country’s spending on prescription drugs.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Roche is back with more data Tuesday for the lead drug it obtained from Carmot Therapeutics — this time from a mid-stage trial in overweight or obese people with type 2 diabetes.
The government of the Region of Murcia is funding nearly 400 day centre places for people living with Alzheimer’s. The […]
A record number of people have been infected with the tick-borne viral disease TBE in Sweden this year.
More than one in five U.S. adults lives with chronic pain, which isolation and stigma can worsen. Group medical visits allow multiple patients with a common condition to receive care alongside health…
Millie joined UCSF Health's clinically integrated network. Founder Anu Sharma says the case she makes to hospital CFOs leaves out what they're really buying.
Centers for Disease Control and Prevention refuses to count four measles deaths in the state though doctors are ‘seeing new forms’ of disease The US Centers of Disease Control and Prevention (CDC)…
